What amount sold does BayBoston Capital Fund III LLC - Series II report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was BayBoston Capital Fund III LLC - Series II's most recent SEC filing?

BayBoston Capital Fund III LLC - Series II's most recent Form D filing was on 2023-07-12.

BayBoston Capital Fund III LLC - Series II

CIK: 0001984389·Pooled Investment Fund·NEWTON CENTER, MA·Limited Liability Company·Founded 2021

Reported Sold

Total Filings

Identified Offerings

Last Filed

Jul 12, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Jul 12, 2023Form D — New notice

Reported sold: $0 · Target: Indefinite

Section 3(c)·0 investors·Section 3(c)(7)

Fundraising Profile

Exemptions

Section 3(c)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Andres Saldana

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 12, 2023	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026